Welcome to the National Allergy Centre of Excellence
Building critical national research infrastructure and collaboration that transforms consumer-centred allergy care.
The National Allergy Centre of Excellence (NACE), hosted at Murdoch Children’s Research Institute, is Australia’s peak allergy research body. Since launching in 2022, it has become one of the largest and most ambitious centres of its kind globally, and is recognised as a European Academy of Allergy and Clinical Immunology (EAACI) Advanced Research Centre.
Backed by an Australia-wide network of more than 460 experts in drug, food, insect, and respiratory allergies, the federal government-funded centre is working to address one of our fastest growing chronic conditions - allergic disease.
Tools and resources platform
Purpose-built allergy research infrastructure to accelerate discovery, access and awareness.
National plan of action
Four pillars of large-scale initiatives to improve evidence-based allergy care across Australia.
Partnering with consumers
A consumer framework to truely embed the voice of lived experience in critical allergy research projects.
NACE Symposium
Allergy experts from across Australia united at the inaugural NACE Symposium to help drive the future of allergy research.
Keynote speakers and in-depth panel discussions covered how to incorporate consumer involvement, digital health and living evidence into our studies.
450+
Children, who presented to emergency with anaphylaxis, had data recorded for analysis
150+
80+ papers and 70+ studies on our national Publications Directory and Allergy Studies Directory
Meet Hunter
At six months old, Hunter had his first taste of peanut butter mixed with breast milk, as recommended. He experienced an allergic reaction, breaking out in full-body hives.
His GP referred him to The Royal Children’s Hospital, Melbourne, where he joined the ADAPT Oral Immunotherapy (OIT) Program in July 2024. Ten paediatric tertiary hospitals across five states partnered with the NACE to introduce the Program and Evaluation Study.
Thanks to this world-first, national standard model of care for treating peanut allergy in babies, Hunter is now slowly building a tolerance to peanut and is on track for remission – a life-changing outcome for him and his family.
“Just to know he could live a normal life without worrying about a peanut exposure would be a massive relief.” – Kirsten Chatwin, Hunter’s mum
NACE News
In proud partnership with
